Lisa von Moltke - Executive Vice President and Chief Medical Officer at Seres Therapeutics, Inc.

Issuer-level insider activity

Role: Executive Vice President and Chief Medical Officer
Issuer ticker: MCRB on Nasdaq
Entity type: Individual
Source filing history: Open source filing history

No buys or sells have been reported by Lisa von Moltke since 13 Aug 2025

Reported holdings for Lisa von Moltke in Seres Therapeutics, Inc.

Form 4 holding Executive Vice President and Chief Medical Officer

Seres Therapeutics, Inc.

Security class: Common Stock
Shares / value: 39,875
Estimated value: $32,319
Report date: 18 Feb 2025
Price: $0.8105
Ownership: Direct

Form 4 holding Executive Vice President and Chief Medical Officer

Seres Therapeutics, Inc.

Security class: Restricted Stock Units
Shares / value: 26,718
Estimated value: $14,446
Report date: 15 Feb 2025
Price: $0.5407
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Executive Vice President and Chief Medical Officer

Seres Therapeutics, Inc.

Security class: Stock Option (Right to Buy)
Shares / value: 650,000
Estimated value
Report date: 07 Feb 2025
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Transaction history for Lisa von Moltke in Seres Therapeutics, Inc.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .